
PHARMA
JW Therapeutics Raises US$90 Million In Series A Funding Round
The funds will be used to further advance JW Therapeutic's chimeric antigen receptor T-cell clinical program, develop a therapeutic pipeline and build a new commercial manufacturing facility.
Johnson & Johnson Innovation Invests US$3.9 Million In Singapore R&D
Three Singapore-based teams working on myopia, cancer and liver disease will receive funding over the next three years.
Takeda Establishes Center Of Excellence In Singapore
Takeda Pharmaceuticals has entered into a multi-year partnership with the Singapore Economic Development Board to support the recruitment and training of local talent for vaccine process optimization.
Cipla To Sell Two Roche Biologics In India
Cipla Ltd. and Roche Products (India) Private Limited have signed a distribution agreement for the promotion and sale of tocilizumab and bevacizumab.
WuXi STA & Regulus To Collaborate On MicroRNA-Targeting Drugs
The partnership is aimed at accelerating Regulus’ oligonucleotide therapeutics programs into the clinic for the treatment of a variety of diseases.
Merck Invests €40 Million In Asia
Merck has invested an additional €40 million (US$49.35 million) to build a robust manufacturing and distribution platform in Asia over a span of two years.
Takeda’s Zika Vaccine Moves Into The Fast Lane
TAK-426, Takeda’s Zika vaccine currently in phase 1 trials, has received US Food and Drug Administration’s Fast Track designation.
WuXi AppTec & Mayo Clinic To Jointly Develop Diagnostics
The collaboration will focus on co-developing new diagnostic tests and offering existing ones to health care providers and patients in China.
Merck Granted CRISPR Patent In Singapore
Merck’s patent covers the successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR gene editing.